FDMT · 4D Molecular Therapeutics, Inc. · Documents
$12.93
+0.97 (+8.11%)
At close · Oct 28
Return incl. dividend (before tax)
Market Cap
$863.27M
Shares
72.18M
Volume · Oct 28
1.19M
Avg daily vol (3M)
996.07K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-08-08 | — | |
| 10-Q | — | 2024-08-08 | 2024-06-30 | |
| 8-K | — | 2024-07-23 | — | |
| 8-K | — | 2024-07-17 | — | |
| 8-K | — | 2024-06-07 | — | |
| 8-K | — | 2024-05-24 | 2024-05-21 | |
| 8-K | — | 2024-05-09 | — | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| DEFA14A | — | 2024-04-10 | — | |
| ARS | — | 2024-04-10 | 2023-12-31 | |
| DEF 14A | — | 2024-04-10 | 2024-05-21 | |
| 10-K | — | 2024-02-29 | 2023-12-31 | |
| 8-K | — | 2024-02-29 | — | |
| 8-K | — | 2024-02-09 | 2024-02-06 | |
| S-3ASR | — | 2024-02-05 | — | |
| 8-K | — | 2024-01-04 | 2024-01-01 | |
| 8-K | — | 2023-11-22 | 2023-11-16 | |
| 8-K | — | 2023-11-09 | — | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-09-13 | 2023-09-11 | |
| 10-Q | — | 2023-08-09 | 2023-06-30 | |
| 8-K | — | 2023-08-09 | — | |
| S-3 | — | 2023-08-09 | — | |
| 8-K | — | 2023-07-11 | 2023-07-05 | |
| 8-K | — | 2023-05-25 | 2023-05-23 | |
| 8-K | — | 2023-05-11 | 2023-05-10 | |
| 10-Q | — | 2023-05-11 | 2023-03-31 | |
| 8-K | — | 2023-05-09 | 2023-05-04 | |
| DEFA14A | — | 2023-04-12 | — | |
| DEF 14A | — | 2023-04-12 | 2023-05-23 | |
| 8-K | — | 2023-03-15 | — | |
| 10-K | — | 2023-03-15 | 2022-12-31 | |
| 8-K | — | 2023-02-03 | 2023-02-02 | |
| 8-K | — | 2023-01-26 | 2023-01-09 | |
| 8-K | — | 2022-11-09 | — | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| 8-K | — | 2022-09-27 | 2022-09-23 | |
| S-3 | — | 2022-08-23 | — | |
| 8-K | — | 2022-08-11 | — | |
| 10-Q | — | 2022-08-11 | 2022-06-30 | |
| 8-K | — | 2022-06-21 | 2022-06-14 | |
| 8-K | — | 2022-05-27 | 2022-05-23 | |
| 8-K | — | 2022-05-12 | — | |
| 10-Q | — | 2022-05-12 | 2022-03-31 | |
| DEFA14A | — | 2022-04-13 | — | |
| DEF 14A | — | 2022-04-13 | 2022-05-23 | |
| S-3 | — | 2022-03-29 | — | |
| 10-K | — | 2022-03-28 | 2021-12-31 | |
| 8-K | — | 2022-03-28 | — | |
| 8-K | — | 2022-02-22 | 2022-02-17 |
Showing 51–100 of 121 filings
Key facts
CIK
1650648
CUSIP
35104E100
13F (30d)
20 filings
20 filers
Visit website
Investor relations